Biodegradation of trace pharmaceutical substances in wastewater by a membrane bioreactor

Gómez M J, Martínez Bueno M J, Lacorte S, Fernández-Alba A R, Agüera A. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere, 2007, 66(6): 993–1002

Nakada N, Tanishima T, Shinohara H, Kiri K, Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Research, 2006, 40(17): 3297–3303

Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicology Letters, 2002, 131(1–2): 5–17

Schwaiger J, Ferling H, Mallow U, Wintermayr H, Negele R D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: Part I histological alterations and bioaccumulation in rainbow trout. Aquatic Toxicology, 2004, 68(2): 141–150

Jobling S, Nolan M, Tyler C R, Brighty G, Sumpter J P. Widespread sexual disruption in wild fish. Environmental Science & Technology, 1998, 32(17): 2498–2506

Daughton C G, Ternes T A. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environmental Health Perspective, 1999, 107(6): 907–944

Urase T, Kagawa C, Kikuta T. Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors. Desalination, 2005, 178(1–3): 107–113

Bernhard M, Müller J, Knepper T P. Biodegradation of persistent polar pollutants in wastewater: Comparison of an optimized labscale membrane bioreactor and activated sludge treatment. Water Research, 2006, 40(18): 3419–3428

Kimura K, Hara H, Watanabe Y. Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs). Desalination, 2005, 178(1–3): 135–140

Ternes T A, Joss A, Siegrist H. Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environmental Science & Technology, 2004, 38(20): 392A–399A